NCT01861288View on ClinicalTrials.gov

Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

157

Participants

Timeline

Start Date

November 1, 2013

Primary Completion Date

September 5, 2016

Study Completion Date

February 28, 2018

Conditions
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative Colitis
Trial Locations (1)

2730

Katrine Carlsen, Herlev

All Listed Sponsors
collaborator

University Hospital of North Norway

OTHER

collaborator

Hvidovre University Hospital

OTHER

lead

Herlev Hospital

OTHER

NCT01861288 - Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter